![]() |
|
|||
|
Amgen Inc. said Friday it filed a new marketing application for its drug candidate denosumab, asking regulators to approve it as a treatment for bone damage suffered by cancer patients.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bone drug from Amgen and Glaxo wins EU approval | cancerfr | Bone Cancer | 0 | 05-29-2010 03:53 PM |
| Amgen seeks cancer approval for bone loss drug | cancerfr | Bone Cancer | 0 | 05-15-2010 02:24 PM |
| Eisai Seeks Approval for Breast Cancer Drug Globally (Update1) (BusinessWeek) | cancerfr | Latest Cancer News | 0 | 03-31-2010 11:05 AM |
| Eisai Seeks Approval for Breast Cancer Drug Globally (Update1) (BusinessWeek) | cancerfr | Breast Cancer | 0 | 03-31-2010 11:05 AM |